[1]Oleszak E, Stewart W E. Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFN-gamma and HuIFN-alpha or HuIFN-beta. Journal of Interferon Research, 1985, 5(2): 361-371.
[2]John A L, Afroza H, Bei S. Beta and gamma interferon act synergistically to produce an antiviral state in cells resistant to both interferons individually. Journal of Virology, 1989, 63(11): 4569-4578.
[3]Peng T, Zhu J, Hwangbo Y, Corey L, Bumgarner R E. Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts. Journal of Virology, 2008, 82(4): 1934-1945.
[4]Jr Sainz B, Halford W P. Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. Journal of Virology, 2002, 76(22): 11541-11550.
[5]Scagnolari C, Trombetti S, Alberelli A, Cicetti S, Bellarosa D, Longo R, Spanò A, Riva E, Clementi M, Antonelli G. The synergistic interaction of interferon types I and II leads to marked reduction in severe acute respiratory syndrome-associated coronavirus replication and increase in the expression of mRNAs for interferon-induced proteins. Intervirology, 2007, 50(2): 156-160.
[6]Scagnolari C, Vicenzi E, Bellomi F, Stillitano M G, Pinna D, Poli G, Clementi M, Dianzani F, Antonelli G. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. Antiviral Therapy, 2004, 9(6): 1003-1011.
[7]Mossel E C, Jr Sainz B, Garry R F, Peters C J. Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN. Advances in Experimental Medicine and Biology, 2006, 581: 503-506.
[8]Okuse C, Rinaudo J A, Farrar K, Wells F, Korba B E. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy. Antiviral Research, 2005, 65(1): 23-34.
[9]Larkin J, Jin L, Farmen M, Venable D, Huang Y, Tan S L, Glass J I. Synergistic antiviral activity of human interferon combinations in the hepatitis C virus replicon system. Journal of Interferon and Cytokine Research, 2003, 23(5): 247-257.
[10]Yao Q, Qian P, Cao Y, He Y, Si Y, Xu Z, Chen H. Synergistic inhibition of pseudorabies virus replication by porcine alpha/beta interferon and gamma interferon in vitro. European Cytokine Network, 2007, 18(2): 71-77.
[11]Mauro P M, Teresa de los S, Marla K, Traci T, He W, Vladimir G A, Marvin J G. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. Journal of Virology, 2007, 81(13): 7124-7135.
[12]Sekellick M J, Lowenthal J W, O'Neil T E, Marcus P I. Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion. Journal of Interferon and Cytokine Research, 1998, 18(6): 407-414.
[13]Rossow K D. Porcine reproductive and respiratory syndrome. Veterinary Pathology, 1998, 35: 1-20.
[14]Albina E, Carrat C, Charley B. Interferon-alpha response to swine arterivirus (PoAV), the porcine reproductive and respiratory syndrome virus. Journal of Interferon and Cytokine Research, 1998, 18(7): 485-490.
[15]Luo R, Xiao S, Jiang Y, Jin H, Wang D, Liu M, Chen H, Fang L. Porcine reproductive and respiratory syndrome virus (PRRSV) suppresses interferon-beta production by interfering with the RIG-I signaling pathway. Molecular Immunology, 2008, 45(10): 2839-2846.
[16]Buddaert W, Van Reeth K, Pensaert M. In vivo and in vitro interferon (IFN) studies with the porcine reproductive and respiratory syndrome virus (PRRSV). Advances in Experimental Medicine and Biology, 1998, 440: 461-467.
[17]Chang H W, Jeng C R, Liu J J, Lin T L, Chang C C, Chia M Y, Tsai Y C, Pang V F. Reduction of porcine reproductive and respiratory syndrome virus (PRRSV) infection in swine alveolar macrophages by porcine circovirus 2 (PCV2)-induced interferon-alpha. Veterinary Microbiology, 2005, 108(3-4): 167-177.
[18]Overend C, Mitchell R, He D, Rompato G, Grubman M, Garmendia A E. Recombinant swine beta interferon protects swine alveolar macrophages and MARC-145 cells from infection with Porcine reproductive and respiratory syndrome virus. The Journal of General Virology, 2007, 88 (3): 925-931.
[19]Wesley R D, Lager K M, Jr Kehrli M E. Infection with Porcine reproductive and respiratory syndrome virus stimulates an early gamma interferon response in the serum of pigs. Canadian Journal of Veterinary Research, 2006, 70(3): 176-182.
[20]Wang Y B, Wang Z Y, Chen H Y, Cui B A, Wang Y B, Zhang H Y, Wang R. Secretory expression of porcine interferon-gamma in baculovirus using HBM signal peptide and its inhibition activity on the replication of porcine reproductive and respiratory syndrome virus. Veterinary Immunology and Immunopathollgy, 2009, 132(2-4): 314-317.
[21]Congote L F, Li Q. Accurate processing and secretion in the baculovirus expression system of an erythroid-cell-stimulating factor consisting of a chimaera of insulin-like growth factor II and an insect insulin-like peptide. The Biochemical Journal, 1994, 299(1): 101-107.
[22]Tessier D C, Thomas D Y, Khouri H E, Laliberte F, Vernet T. Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide. Gene, 1991, 98(2): 177-183.
[23]Weyer U, Possee R D. A baculovirus dual expression vector derived from the Autographa californica nuclear polyhedrosis virus polyhedrin and p10 promoters: co-expression of two influenza virus genes in insect cells. Journal of General Virology, 1991, 72(12): 2967-2974.
[24]Vihko P, Kurkela R, Porvari K, Herrala A, Lindfors A, Lindqvist Y, Schneider G. Rat acid phosphatase: overexpression of active, secreted enzyme by recombinant baculovirus-infected insect cells, molecular properties, and crystallization. Procceedings of the National Academy of Sciences, USA, 1993, 90(3): 799-803.
[25]Marinaro J A, Casley D J, Bach L A. O-glycosylation delays the clearance of human IGF-binding protein-6 from the circulation. European Journal of Endocrinology, 2000, 142(5): 512-516.
[26]Tan H, Derrick J, Hong J, Sanda C, Grosse W M, Edenberg H J, Taylor M, Seiwert S, Blatt L M. Global transcriptional profiling demonstrates the combination of type I and type II interferon enhances antiviral and immune responses at clinically relevant doses. Journal of Interferon and Cytokine Research, 2005, 25(10): 632-649.
[27]Sanda C, Weitzel P, Tsukahara T, Schaley J, Edenberg H J, Stephens M A, McClintick J N, Blatt LM, Li L, Brodsky L, Taylor M W. Differential gene induction by type I and type II interferons and their combination. Journal of Interferon and Cytokine Research, 2006, 26(7): 462-472.
[28]Marchetti M, Monier M N, Fradagrada A, Fradagrada A, Mitchell K, Baychelier F, Eid P, Johannes L, Lamaze C. Stat-mediated signaling induced by type I and type II interferons (IFNs) is differentially controlled through lipid microdomain association and clathrin- dependent endocytosis of IFN receptors. Molecular Biology of the Cell, 2006, 17(7): 2896-2909.
[29]王彦彬, 崔保安, 陈红英, 王亚宾, 张红英, 魏战勇. 猪干扰素α在昆虫细胞中分泌表达及其抗病毒活性检测. 中国农业科学, 2009, 42(4): 1435-1441.
Wang Y B, Cui B A, Chen H Y, Wang Y B, Zhang H Y, Wei Z Y. Secreted expression of porcine interferon-alpha in insect cells and its antiviral activity detection. Scientia Agricultura Sinica, 2009, 42(4): 1435-1441. (in Chinese) |